Clinical Trial Update: Study of Prevention of Postoperative Nausea and Vomiting Using Cesamet [Phase 2]

View source ↗

Summary

A Phase 2 trial of Cesamet (nabilone) for preventing postoperative nausea and vomiting has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting

Drugs mentioned

• CESAMET (nabilone)

Snippet

Sponsor: Unity Health Toronto | Conditions: Postoperative Nausea and Vomiting | Phase 2 | Status: COMPLETED